Molecules / Iohexol

Iohexol API manufacturers

CAS 66108-95-0 ATC V08AB02 Updated 9 July 2026
13
manufacturers with an active filing 9 of them hold a US DMF or a CEP
25
shortage records on file across 4 countries
152
finished-dose makers across 45 regulators
Showing 13 of 13 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

02

GE Healthcare

Norway
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for iohexol, filing since 2021. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 21 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2024 · VAI
GMP recognised in
21 markets
How this listing is sourced EDQM certificate database
View profile
03

Divi's Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for iohexol, filing since 2025. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2025 · NAI
GMP recognised in
2 markets
How this listing is sourced EDQM certificate database
View profile
05

Divi'S Labotatories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for iohexol, filing since 2023.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
08

Jiangxi Brother Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for iohexol, filing since 2024.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile
10

Registered with PMDA (Japan) for iohexol.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

Registered with PMDA (Japan) for iohexol.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
12

Zhejian Starry Pharmaceuticals

China
Makes the API

Registered with SFDA (Saudi Arabia) for iohexol.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

Registered with SFDA (Saudi Arabia) for iohexol.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

Contract manufacturers (4)

Zhejiang Haizhou Pharmaceutical China Hongkong Roundcare China Onko İlaç Sanayi̇ Veti̇caret A.Ş Turkey Yangtze River Pharmaceutical Group China

Contract manufacturers make to order rather than holding their own filing for this molecule.

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map iohexol for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

By country